USPTO serial 76568022
CG CHONDROGENE
Reviewed by CopyMark Law Group
Reg. 3656206Status 710
- Filing date
- Status date
- Registration date
- Jul 21, 2009
- Examiner
- POWERS, ALEXANDER L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with CG CHONDROGENE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Toronto, Ontario, CA
Richmond Hill, CA
Richmond Hill, CA
Richmond Hill, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew S. Ehard
ANDREW S. EHARD MERCHANT & GOULD P.C.PO BOX 2910MINNEAPOLIS, MN 55402-0910UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | (Based on Use in Commerce) (Based on 44(e)) Diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA and cDNA clones for medical research and development use; (Based on on 44(e)) Diagnostic assays and test kits for use in laboratory, medical research and chemical research and development; Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognoses or predict diseases for research use; Prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment for research use | SECTION 8 - CANCELLED | Jan 7, 2003 |
| 005 | (Based on 44(e)) Diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, proteins and antibodies, and molecular arrays of biological material for medical laboratory use; Diagnostic assays and test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for use to diagnose, prognoses or predict diseases for clinical or medical use; Prognostic test kits containing nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies and molecular arrays of biological material, for identifying disease risk factors and responses to therapeutic treatment for clinical or medical use; diagnostic preparations, namely, preparations of assays, nucleic acid primers, nucleic acid probes, enzymes, buffers, proteins, antibodies, and molecular arrays of biological material for clinical or medical use; diagnostic preparations, namely, preparations of extracts and nucleic acids, namely, RNA and cDNA clones for clinical use | SECTION 8 - CANCELLED | — |
| 042 | (Based on Use in Commerce) (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of biology, systems biology, biochemistry, molecular biology and genomics; (Based on 44(e)) Research and development, validation testing, data analysis and product development in the fields of pharmacogenomics, toxicogenomics and personalized medicine; Evaluation of clinical trial progress, and drug monitoring and monitoring of patient health progression as it relates to experimental research | SECTION 8 - CANCELLED | Nov 18, 2002 |
| 044 | (Based on 44(e)) Diagnostic services, namely, diagnosing, preventing and predicting disease, identifying disease risk factors, diagnostic testing, gene and protein testing, identifying physiological characteristics, establishing individual preventative care programs, establishing disease treatment based on gene and protein expression and/or activity; providing genomic, proteomic and gene expression profiles useful in selecting therapeutics, evaluating the efficacy and toxicity of treatments and evaluating treatment progression, prognosing disease or disease progression and identifying disease heredity risk factors | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ChondroGene Limited
- Other trademarks owned by GENENEWS LIMITED
- Other trademarks owned by GENENEWS LIMITED
- Other trademarks owned by GENENEWS LIMITED
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CG CHONDROGENE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 26, 2016 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Jul 21, 2009 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 17, 2009 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Jun 17, 2009 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 16, 2009 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Jun 16, 2009 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Dec 30, 2008 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 7, 2008 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 17, 2008 | NPUB | NOTICE OF PUBLICATION | — |
| Sep 4, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Aug 28, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 28, 2008 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Aug 27, 2008 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 27, 2008 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 14, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 13, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 13, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 18, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 5, 2008 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 28, 2008 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Apr 11, 2008 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 10, 2008 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 8, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 8, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 8, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 9, 2007 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 8, 2007 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 18, 2007 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Oct 5, 2007 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Sep 21, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 20, 2007 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 20, 2007 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 19, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 12, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 12, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 22, 2007 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 6, 2007 | PAPER RECEIVED | — | |
| Mar 29, 2007 | CPRA | PRIORITY ACTION MAILED | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Mar 28, 2007 | CPRA | PRIORITY ACTION WRITTEN | A priority action is a type of Office Action the USPTO treats as time-sensitive. It usually means the examining attorney needs a specific response or amendment quickly — often relating to a foreign priority claim or a formal requirement. Respond within the stated deadline. |
| Feb 12, 2007 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Feb 5, 2007 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Jan 14, 2007 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 12, 2007 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 12, 2007 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jan 12, 2007 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2007 | ALIE | ASSIGNED TO LIE | — |
| Dec 11, 2006 | PAPER RECEIVED | — | |
| Oct 23, 2006 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Oct 20, 2006 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Oct 13, 2006 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Sep 5, 2006 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 5, 2006 | PAPER RECEIVED | — | |
| Jun 20, 2006 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 20, 2006 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 13, 2006 | CNSI | INQUIRY AS TO SUSPENSION MAILED | — |
| Mar 12, 2006 | CNSI | SUSPENSION INQUIRY WRITTEN | — |
| Sep 12, 2005 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Sep 9, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Sep 9, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Aug 16, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 16, 2005 | PAPER RECEIVED | — | |
| Mar 23, 2005 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Mar 23, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Mar 23, 2005 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 14, 2005 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Mar 13, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Feb 23, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jan 31, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 31, 2005 | PAPER RECEIVED | — | |
| Aug 2, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 20, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 14, 2004 | NWAP | NEW APPLICATION ENTERED | — |